(Q40327201)

English

Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein

scientific article published on March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

DiMartino JF

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Lacayo NJ

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Varadi M

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Li L

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Saraiya C

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Ravindranath Y

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yu R

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sikic BI

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Raimondi SC

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Dahl GV

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

426-432

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Identification of the haematopoietic stem cell niche and control of the niche size

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Osteoblastic cells regulate the haematopoietic stem cell niche

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

SPARC and tumor growth: where the seed meets the soil?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

SPARC, a matricellular glycoprotein with important biological functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

SPARC, a matricellular protein: at the crossroads of cell-matrix communication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Significance analysis of microarrays applied to the ionizing radiation response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Leukemia-lymphoma cell lines as model systems for hematopoietic research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Mll rearrangements in haematological malignancies: lessons from clinical and biological studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Mechanisms of transformation by MLL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Gene expression profiling of pediatric acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

SPARC Inhibits Epithelial Cell Proliferation in Part through Stimulation of the Transforming Growth Factor-β–Signaling System

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

21 January 2018

Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

7 January 2021

based on heuristic

inferred from DOI database lookup

SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

7 January 2021

based on heuristic

inferred from DOI database lookup

SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404102

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404102

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40327201&oldid=2203605565"